Fujian Wanchen Biotechnology Group Balance Sheet Health
Financial Health criteria checks 5/6
Fujian Wanchen Biotechnology Group has a total shareholder equity of CN¥1.2B and total debt of CN¥1.3B, which brings its debt-to-equity ratio to 105.2%. Its total assets and total liabilities are CN¥6.5B and CN¥5.3B respectively. Fujian Wanchen Biotechnology Group's EBIT is CN¥648.2M making its interest coverage ratio 15.7. It has cash and short-term investments of CN¥2.3B.
Key information
105.2%
Debt to equity ratio
CN¥1.25b
Debt
| Interest coverage ratio | 15.7x |
| Cash | CN¥2.29b |
| Equity | CN¥1.19b |
| Total liabilities | CN¥5.27b |
| Total assets | CN¥6.46b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 300972's short term assets (CN¥4.9B) exceed its short term liabilities (CN¥4.6B).
Long Term Liabilities: 300972's short term assets (CN¥4.9B) exceed its long term liabilities (CN¥680.6M).
Debt to Equity History and Analysis
Debt Level: 300972 has more cash than its total debt.
Reducing Debt: 300972's debt to equity ratio has increased from 64.2% to 105.2% over the past 5 years.
Debt Coverage: 300972's debt is well covered by operating cash flow (164%).
Interest Coverage: 300972's interest payments on its debt are well covered by EBIT (15.7x coverage).